Answers are grounded in this paper and cite their sources.
Randomized trial investigates the role of circRERE in cardiomyocyte apoptosis, indicating a novel therapeutic target for myocardial infarction.
Acute myocardial infarction (AMI) causes high mortality, with cardiomyocyte apoptosis playing a critical role. Although circular RNAs modulate cardiac disorders, related mechanisms remain unclear. Here, we identify circRERE as a previously unrecognized pro-apoptotic regulator under ischemic stress. circRERE is markedly upregulated in ischemic myocardium and promotes apoptosis by sponging miR-27a-3p to elevate Caspase9. Using epigallocatechin gallate-primed exosomes (EGCG-primed exosomes, ExoEGCG) as a tool to modulate circRERE, we found that ExoEGCG significantly reduced circRERE levels, restored miR-27a-3p activity, and suppressed Caspase9. Gain- and loss-of-function tests confirmed that circRERE mediates ExoEGCG-derived protection. Collectively, circRERE represents a novel and actionable target for AMI, with ExoEGCG serving as an effective delivery platform.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: